CDKN2A and in situ carcinoma: After the application of inclusion criteria, we excluded 3 patients with visceral melanoma and 54 others that did not exhibit either personal or familial characteristics superposable to CDKN2A positivity; no case of melanoma in situ was detected in the analyzed individuals.